Jun 30, 2022 7:30 am EDT BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Jun 22, 2022 7:30 am EDT BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Jun 13, 2022 7:00 am EDT BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Apr 29, 2022 8:00 am EDT BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Apr 18, 2022 8:00 am EDT BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Apr 4, 2022 8:00 am EDT BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification
Mar 10, 2022 8:00 am EST BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program
Feb 16, 2022 8:30 am EST BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
Feb 7, 2022 9:00 am EST BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway